FDA clears Ares robot-assisted bronchoscopy device from Auris Surgical Robotics

June 8, 2016 By Brad Perriello

The FDA last month granted 510(k) clearance to the Ares robot-assisted bronchoscopy platform developed by stealthy Auris Surgical Robotics.

San Carlos, Calif.-based Auris was co-founded by medical robotics pioneer Dr. Frederic Moll, who’s behind a slew of other startups in the space, including market leader Intuitive Surgical (NSDQ:ISRG); Mako Surgical, acquired in 2013 for $1.7 billion by Stryker (NYSE:SYK); Restoration Robotics and its Artas hair restoration platform; and Hansen Medical, which Auris agreed to acquire for $80 million in April.

Auris revealed in a September 2015 regulatory filing that it reeled in a $150 million funding round from 25 unnamed investors. And in April 2014, Auris said it raised more than $34 million in an equity round from 20 backers; that filing listed several executives from private equity shops as directors, including Ajay Royan of Mithril Capital Management, Robert Higgins of Highland Capital Partners, Peter Hébert of Lux Capital and Dr. Bijan Salehizadeh of the NaviMed Capital.

In October 2013, Auris and Biolase (NSDQ:BIOL) inked a deal to collaborate on developing a cataract-removal ophthalmologic robot, using Biolase’s WaterLase cutting technology to create a prototype.

Think Surgical robot can use Ortho Development implants, FDA says
The FDA has cleared two Ortho Development knee implants for use with a Think Surgical robotic system, the companies announced today. Surgeons will now be able to use Ortho Development’s Balanced Knee system (BKS) and BKS TriMax implants with Think Surgical’s TSolution One total knee arthroplasty system. TSolution One is the only commercially available active… […]
NXgenPort, Mayo Clinic ink license agreement over chemo-port catheter for home monitoring
NXgenPort today announced that it has entered into a license agreement with Mayo Clinic to develop and test an implantable chemo-port catheter. NXgenPort’s technology has chemo-port efficacy with sensor technology to measure and remotely monitor the early onset of complications by reporting and tracking patient response during treatment. Get the full story on our sister site,… […]
Women execs to discuss leadership during pandemic
AdvaMed’s Women’s Executive Network has scheduled a one-day conference for Wednesday, May 19. Future of Medtech: Leading with Resilience, Agility and Empathy will be a virtual event featuring a range of executives from the medical device and corporate world to discuss issues pertaining to leadership throughout the COVID-19 pandemic. Scheduled speakers include: Jessica C. Johnston,… […]
BWXT Medical to make TheraSphere microspheres for Boston Scientific
BWXT Medical announced today that it entered into a long-term, mutually exclusive agreement to manufacture Boston Scientific’s TheraSphere. Ottawa, Ontario-based BWXT’s new deal with Boston Scientific covers manufacturing of the TheraSphere Y-90 glass microspheres from the Marlborough, Mass.-based medtech company. Get the full story at our sister site, MassDevice. The post BWXT Medical to make TheraSphere microspheres […]
Spartech sold to private equity firm
A private equity firm has purchased Spartech in partnership with Spartech’s existing management team, the companies announced today. Headquartered in St. Louis, Mo., Spartech has an innovation center and 14 U.S. manufacturing facilities producing engineered thermoplastic materials and specialty packaging products. The new owner is an affiliate of private equity firm The Jordan Company (TJC).… […]
Sunrise Labs adds solar panels
Medical device development firm Sunrise Labs announced that it recently had a 118kW solar array installed at its Bedford, N.H. office. The system comprises 267 photovoltaic panels that are expected to produce over 100 megawatt-hours of electricity each year. “We believe that climate change affects everyone’s lives deeply and we hope that we’re setting an… […]
New ethylene oxide regulations now expected in 2022
The EPA now estimates that it will propose new regulations for medical device sterilizers’ emissions of ethylene oxide (EtO) in 2022. The EPA in 2019 issued an advance notice of proposed new regulations for the cancer-causing gas used by medical device sterilizers but has yet to produce the proposal. Now the EPA’s inspector general wants… […]
Medical Wearables Solution Guide
Boyd has leveraged decades of experience to develop a quick Guide to Engineered Materials and Thermal Solutions for optimized Medical Wearables. This guide covers technologies necessary to protect, seal, and cool these small, but vital devices while improving reliability, connectivity, accuracy, and user safety. The article also highlights how to best utilize these technologies to… […]
3D ‘lung-on-a-chip’ will test COVID-19 drugs
Researchers in Boston have developed a novel technology to study the effects of COVID-19 on lung tissue, and to test treatments for it. The “3-D lung-on-a-chip” by Brigham & Women’s Hospital researchers models the distal lung and alveolar structures — the tiny air sacs that take in oxygen as you breathe. They are studying how… […]
FDA maps return to inspection normalcy
The FDA has mapped out how it plans to catch up on pandemic-delayed facility inspections — including 2,426 medtech inspections. In a new report called Resiliency Roadmap for FDA Inspectional Oversight, the agency said it will prioritize inspections in terms of urgency and the threat posed by COVID-19 domestically and abroad. The FDA had planned… […]
Zimmer Biomet is looking to put sensors in more than just knee implants
Even as Zimmer Biomet prepares to launch its Persona-IQ smart knee implant later this year, the ortho device giant is looking at additional opportunities to package sensors inside ortho implants. Startup Canary Medical (Vancouver, British Columbia), which created the Canary Health Implantable Reporting Processor (CHIRP) that is going inside the Persona-IQ, has cemented a long-term… […]